Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Inhibition of glial proliferation, promotion of axonal growth and myelin production by synthetic glycolipid: A new approach for spinal cord injury treatment.
Neurorestorative effect of FTY720 in a rat model of Alzheimer's disease: Comparison with Memantine.
Cognitive and Behavioral Outcomes in Individuals With a History of Acute Disseminated Encephalomyelitis (ADEM).
Suppression of Experimental Autoimmune Optic Neuritis by the Novel Agent Fingolimod.
Spatial and temporal characteristics of gait as outcome measures in multiple sclerosis (EDSS 0 to 6.5).
Melatonin pathway genes are associated with progressive subtypes and disability status in multiple sclerosis among Finnish patients.
Vitamin D-binding protein and vitamin D status of black Americans and white Americans.
Transgenic inhibition of astroglial NF-kappaB protects from optic nerve damage and retinal ganglion cell loss in experimental optic neuritis.
The Ambivalent Role of Apoptosis in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.
The attributable burden of panic disorder in the impairment of quality of life in a national survey in Italy.
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.
A possible case of natalizumab-dependent suicide attempt: A brief review about drugs and suicide.
Central Nervous System and its Disease Models on a Chip.
An evidence-based review of natalizumab therapy in the management of Crohn's disease.
Negative feedback control of the autoimmune response through antigen-induced differentiation of IL-10-secreting Th1 cells.
Role of Proangiogenic Factors in Immunopathogenesis of Multiple Sclerosis.
Suppression of Brain Mast Cells Degranulation Inhibits Microglial Activation and Central Nervous System Inflammation.
Olfactory dysfunction in multiple sclerosis.
Correlation of nitric oxide levels in the cerebellum and spinal cord of experimental autoimmune encephalomyelitis rats with clinical symptoms.
Intraventricularly injected Olig2-NSCs attenuate established relapsing-remitting EAE in mice.
Multiple sclerosis and pain.
Review of MR elastography applications and recent developments.
Pathophysiology of the brain extracellular matrix: a new target for remyelination.
Dalfampridine improves walking speed, walking endurance, and community participation in veterans with multiple sclerosis: a longitudinal cohort study.
[Inflammatory brain pseudotumor. A variant of demyelinating disease that simulates high-grade glioma].
Pages
« first
‹ previous
…
195
196
197
198
199
200
201
202
203
…
next ›
last »